Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/09/2023) announced the following final list of price concessions for September 2023:
Atorvastatin 80mg tablets
Brimonidine 0.2% eye drops
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment
Clarithromycin 500mg tablets
Cyclizine 50mg tablets
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops
Flucloxacillin 250mg/5ml oral solution
Itraconazole 100mg capsules
Lansoprazole 30mg orodispersible tablets
Letrozole 2.5mg tablets
Mebeverine 200mg modified-release capsules
Midazolam 10mg/2ml solution for injection ampoules
Naftidrofuryl 100mg capsules
Pantoprazole 40mg gastro-resistant tablets
Phenoxymethylpenicillin 125mg/5ml oral solution
Rasagiline 1mg tablets
Rizatriptan 10mg orodispersible tablets sugar free
Ropinirole 2mg tablets
Ropinirole 500 micrograms tablets
Topiramate 100mg tablets
Valaciclovir 500mg tablets
Warfarin 1mg tablets
For the full list of price concessions granted so far for September 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.